{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T09:46:17Z","timestamp":1775382377755,"version":"3.50.1"},"reference-count":34,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2020,10,31]]},"DOI":"10.5582\/bst.2020.03230","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T22:11:37Z","timestamp":1595628697000},"page":"368-375","source":"Crossref","is-referenced-by-count":13,"title":["High platelet count as a poor prognostic factor for liver cancer patients without cirrhosis"],"prefix":"10.5582","volume":"14","author":[{"given":"Yutaka","family":"Midorikawa","sequence":"first","affiliation":[{"name":"Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadatoshi","family":"Takayama","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokio","family":"Higaki","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Aramaki","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Teramoto","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Genome Science Division, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nihon University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiko","family":"Moriyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nihon University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012; 379:1245-1255.","DOI":"10.1016\/S0140-6736(11)61347-0"},{"key":"2","unstructured":"2. Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, Ramacciato G, Grazi GL, Pinna AD. Is portal hypertension a contraindication to hepatic resection? Ann Surg. 2009; 250:922-928."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, Imamura H, Sugawara Y, Kokudo N, Makuuchi M. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008; 134:1908-1916.","DOI":"10.1053\/j.gastro.2008.02.091"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ohkubo T, Midorikawa Y, Nakayama H, Moriguchi M, Aramaki O, Yamazaki S, Higaki T, Takayama T. Liver resection of hepatocellular carcinoma in patients with portal hypertension and multiple tumors. Hepatol Res. 2018; 48:433-441.","DOI":"10.1111\/hepr.13047"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lesurtel M, Clavien PA. Platelet-derived serotonin: translational implications for liver regeneration. Hepatology. 2014; 60:30-33.","DOI":"10.1002\/hep.27067"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Padickakudy R, Pereyra D, Offensperger F, Jonas P, Oehlberger L, Schwarz C, Haegele S, Assinger A, Brostjan C, Gruenberger T, Starlinger P. Bivalent role of intra-platelet serotonin in liver regeneration and tumor recurrence in humans. J Hepatol. 2017; 67:1243-1252.","DOI":"10.1016\/j.jhep.2017.08.009"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lisman T, Porte RJ. Mechanisms of platelet-mediated liver regeneration. Blood. 2016; 128:625-629.","DOI":"10.1182\/blood-2016-04-692665"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Han S, Park HW, Song JH, Gwak MS, Lee WJ, Kim G, Lee SK, Ko JS. Association Between Intraoperative Platelet Transfusion and Early Graft Regeneration in Living Donor Liver Transplantation. Ann Surg. 2016; 264:1065-1072.","DOI":"10.1097\/SLA.0000000000001526"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yamazaki S, Takayama T, Mitsuka Y, Aoki M, Midorikawa Y, Moriguchi M, Higaki T. Platelet recovery correlates parenchymal volume recovery after liver resection. Hepatol Res. 2020; 50:620-628.","DOI":"10.1111\/hepr.13488"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Alkozai EM, Nijsten MW, de Jong KP, de Boer MT, Peeters PM, Slooff MJ, Porte RJ, Lisman T. Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection. Ann Surg. 2010; 251:300-306.","DOI":"10.1097\/SLA.0b013e3181b76557"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Li L, Wang H, Yang J, Jiang L, Yang J, Wang W, Yan L, Wen T, Li B, Xu M. Immediate Postoperative Low Platelet Counts After Living Donor Liver Transplantation Predict Early Allograft Dysfunction. Medicine (Baltimore). 2015; 94:e1373.","DOI":"10.1097\/MD.0000000000001373"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Carr BI, Cavallini A, D&apos;Alessandro R, Refolo MG, Lippolis C, Mazzocca A, Messa C. Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma <i>in vitro<\/i>. BMC Cancer. 2014; 14:43.","DOI":"10.1186\/1471-2407-14-43"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011; 20:576-590.","DOI":"10.1016\/j.ccr.2011.09.009"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. D&apos;Alessandro R, Refolo MG, Lippolis C, Giannuzzi G, Carella N, Messa C, Cavallini A, Carr BI. Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines. BMC Cancer. 2014; 14:351.","DOI":"10.1186\/1471-2407-14-351"},{"key":"15","unstructured":"15. Shu B, Wang S, Deng Y, Zhai M, Liu S. Intra-platelet serotonin in prognosis of tumorigenesis: Friend or foe? J Hepatol. 2018; 68:1333-1334."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Liu PH, Hsu CY, Su CW, Huang YH, Hou MC, Rich NE, Fujiwara N, Hoshida Y, Singal AG, Huo TI. Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma. Liver Int. 2020 (<i>in press<\/i>)","DOI":"10.1111\/liv.14560"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Morimoto Y, Nouso K, Wada N, Takeuchi Y, Kinugasa H, Miyahara K, Yasunaka T, Kuwaki K, Onishi H, Ikeda F, Miyake Y, Nakamura S, Shiraha H, Takaki A, Yamamoto K. Involvement of platelets in extrahepatic metastasis of hepatocellular carcinoma. Hepatol Res. 2014; 44:E353-359.","DOI":"10.1111\/hepr.12315"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lee CH, Lin YJ, Lin CC, Yen CL, Shen CH, Chang CJ, Hsieh SY. Pretreatment platelet count early predicts extrahepatic metastasis of human hepatoma. Liver Int. 2015; 35:2327-2336.","DOI":"10.1111\/liv.12817"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Han S, Lee S, Yang JD, Leise MD, Ahn JH, Kim S, Jung K, Gwak MS, Kim GS, Ko KJS. Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation. Liver Transpl. 2018; 24:44-55.","DOI":"10.1002\/lt.24961"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kokudo N, Hasegawa K, Akahane M, <i>et al.<\/i> Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res. 2015; 45:123-127.","DOI":"10.1111\/hepr.12464"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S. Surgery for small liver cancers. Semin Surg Oncol. 1993; 9:298-304.","DOI":"10.1002\/ssu.2980090404"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Takayama T, Makuuchi M, Kubota K, Harihara Y, Hui AM, Sano K, Ijichi M, Hasegawa K. Randomized comparison of ultrasonic <i>vs.<\/i> clamp transection of the liver. Arch Surg. 2001; 136:922-928.","DOI":"10.1001\/archsurg.136.8.922"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240:205-213.","DOI":"10.1097\/01.sla.0000133083.54934.ae"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Midorikawa Y, Kubota K, Takayama T, Toyoda H, Ijichi M, Torzilli G, Mori M, Makuuchi M. A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease. Surgery. 1999; 126:484-491.","DOI":"10.1016\/S0039-6060(99)70089-9"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Midorikawa Y, Takayama T, Shimada K, Nakayama H, Higaki T, Moriguchi M, Nara S, Tsuji S, Tanaka M. Marginal survival benefit in the treatment of early hepatocellular carcinoma. J Hepatol. 2013; 58:306-311.","DOI":"10.1016\/j.jhep.2012.09.026"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Nouso K, Ito Y, Kuwaki K, Kobayashi Y, Nakamura S, Ohashi Y, Yamamoto K. Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis. Br J Cancer. 2008; 98:1161-1165.","DOI":"10.1038\/sj.bjc.6604282"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Scheiner B, Kirstein M, Popp S, Hucke F, Bota S, Rohr-Udilova N, Reiberger T, M\u00fcller C, Trauner M, Peck Radosavljevic M, Vogel A, Sieghart W, Pinter M. Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma. Liver Cancer. 2019; 8:203-217.","DOI":"10.1159\/000489833"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Yamamoto S, Midorikawa Y, Nagae G, Tatsuno K, Ueda H, Moriyama M, Takayama T, Aburatani H. Spatial and temporal expansion of intrahepatic metastasis by molecularly-defined clonality in multiple liver cancers. Cancer Sci. 2020; 111:601-609.","DOI":"10.1111\/cas.14282"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Cucchetti A, Piscaglia F, Caturelli E, Benvegn\u00f9 L, Vivarelli M, Ercolani G, Cescon M, Ravaioli M, Grazi GL, Bolondi L, Pinna AD. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann Surg Oncol. 2009; 16:413-422.","DOI":"10.1245\/s10434-008-0232-4"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Sasaki K, Shindoh J, Margonis GA, Nishioka Y, Andreatos N, Sekine A, Hashimoto M, Pawlik TM. Effect of Background Liver Cirrhosis on Outcomes of Hepatectomy for Hepatocellular Carcinoma. JAMA Surg. 2017; 152:e165059.","DOI":"10.1001\/jamasurg.2016.5059"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Pang Q, Qu K, Zhang JY, Song SD, Liu SS, Tai MH, Liu HC, Liu C. The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Medicine (Baltimore). 2015;94:e1431.","DOI":"10.1097\/MD.0000000000001431"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Aramaki O, Takayama T, Higaki T, Nakayama H, Ohkubo T, Midorikawa Y, Moriguchi M, Matsuyama Y. Decreased blood loss reduces postoperative complications in resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2014;21:585-591.","DOI":"10.1002\/jhbp.101"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Takahashi K, Liang C, Oda T, Ohkohchi N. Platelet and liver regeneration after liver surgery. Surg Today. DOI: 10.1007\/s00595-019-01890-x.","DOI":"10.1007\/s00595-019-01890-x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Nathan H, Herlong HF, Gurakar A, Li Z, Koteish AA, Bridges JF, Pawlik TM. Clinical decision-making by gastroenterologists and hepatologists for patients with early hepatocellular carcinoma. Ann Surg Oncol. 2014;21:1844-1851.","DOI":"10.1245\/s10434-014-3536-6"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/14\/5\/14_2020.03230\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T03:44:27Z","timestamp":1604720667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/14\/5\/14_2020.03230\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,31]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2020.03230","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,31]]}}}